» Authors » Sylwia Popek-Marciniec

Sylwia Popek-Marciniec

Explore the profile of Sylwia Popek-Marciniec including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 12
Citations 67
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Zmorzynski S, Popek-Marciniec S, Biernacka B, Szudy-Szczyrek A, Chocholska S, Styk W, et al.
Genes (Basel) . 2024 Mar; 15(3). PMID: 38540446
Background: Multiple myeloma (MM) is a malignancy derived from plasma cells. Bortezomib affects the concentration of reduced glutathione (GSH) and the activity of glutathione enzymes. The aim of our study...
2.
Popek-Marciniec S, Styk W, Wojcierowska-Litwin M, Chocholska S, Szudy-Szczyrek A, Samardakiewicz M, et al.
Cancers (Basel) . 2023 Oct; 15(19). PMID: 37835441
Multiple myeloma (MM) is a multifactorial genetic disorder caused by interactive effects of environmental and genetic factors. The proper of the gene (17p13.1) and its protein is essential in genomic...
3.
Popek-Marciniec S, Zmorzynski S, Koczkodaj D, Marciniec M, Wasik-Szczepanek E, Karczmarczyk A, et al.
Acta Haematol . 2023 Apr; 146(4):277-286. PMID: 37015191
Introduction: Both microenvironmental signals from surrounding cells and changes in the genome of leukemic cells play essential role in the development of chronic lymphocytic leukemia. Nurse-like cells (NLCs) are one...
4.
Popek-Marciniec S, Styk W, Wojcierowska-Litwin M, Szudy-Szczyrek A, Dudek P, Swiderska-Kolacz G, et al.
J Clin Med . 2023 Mar; 12(6). PMID: 36983384
(1) Background: Chemokines and chemokine receptors play an important role in tumor development. The aim of this study was to check the significance of and variants with response rate, survival,...
5.
Pawlicka M, Zmorzynski S, Popek-Marciniec S, Filip A
Int J Mol Sci . 2022 Oct; 23(20). PMID: 36293214
This study aimed to evaluate the safety and potential use of soy isoflavones in the treatment of skin problems, difficult-to-heal wounds and postoperative scars in women after the oncological treatment...
6.
Koczkodaj D, Zmorzynski S, Grygalewicz B, Pienkowska-Grela B, Styk W, Popek-Marciniec S, et al.
J Clin Med . 2022 Apr; 11(7). PMID: 35407481
(1) Background: The aim of our study was the complex assessment of WT1 variants and their expression in relation to chromosomal changes and molecular prognostic markers in acute myeloid leukemia...
7.
Zmorzynski S, Wojcierowska-Litwin M, Popek-Marciniec S, Szudy-Szczyrek A, Styk W, Chocholska S, et al.
J Clin Med . 2021 Nov; 10(22). PMID: 34830558
(1) Background: The aim of our study was to analyze the possible relationship of and gene variants with susceptibility and outcome of multiple myeloma (MM); (2) Methods: Genomic DNA samples...
8.
Zmorzynski S, Popek-Marciniec S, Szudy-Szczyrek A, Wojcierowska-Litwin M, Korszen-Pilecka I, Chocholska S, et al.
Front Oncol . 2019 Nov; 9:1056. PMID: 31681592
Oxidative stress and systemic inflammation are closely linked with increased risk of cancer development. Tumor necrosis factor alpha (TNF-α) is one of the pro-inflammatory cytokines. Glutathione S-transferases (GSTs) are enzymes...
9.
Marciniec M, Sapko K, Kulczynski M, Popek-Marciniec S, Szczepanska-Szerej A, Rejdak K
Clin Neurol Neurosurg . 2019 Oct; 187:105561. PMID: 31634685
Cervical artery dissection (CAD) is a leading cause of ischaemic stroke (IS) in young and middle-aged adults. Despite well characterized clinical presentation, the diagnosis of CAD can be quite challenging...
10.
Koczkodaj D, Popek-Marciniec S, Zmorzynski S, Wasik-Szczepanek E, Filip A
Med Oncol . 2019 Aug; 36(9):79. PMID: 31375939
Chronic lymphocytic leukemia (CLL) is one of the most frequent lymphoproliferative diseases. CLL is characterized by unusual heterogeneity, which probably reflects its biological and genetic lack of homogeneity. Clonal chromosome...